⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Eurofins Central Laboratory and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Eurofins Central Laboratory
↗Lancaster, PA, USA
Eurofins Central Laboratory is a prominent division of the Eurofins Scientific network, specializing in comprehensive, high-quality clinical laboratory testing solutions for the biopharmaceutical industry. It provides end-to-end support for clinical trials, including project management, biomarker services, bioanalytical testing, and clinical trial supplies across a global network of facilities.
The company operates as part of the broader Eurofins Clinical Trial Solutions network, which integrates various specialized laboratories to offer seamless, harmonized data and testing services. With over 25 years of experience, it supports multi-center, multi-country studies in more than 85 countries, adhering to stringent regulatory standards such as GCLP, GCP, and CLIA.
CLASSIFICATION
SIZE & FINANCIALS
Employees:10000+
Founded:1987
Ownership:subsidiary
Status:operating
STOCK
Exchange:Euronext Paris
Ticker:ERF
PIPELINE
Modalities:Small molecule, mAb, ADC, Cell therapy, Gene therapy
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Eurofins Scientific
Key Partnerships:Pharma and biotech companies globally, Clinical CROs
COMPETITION
Position:Leader
Competitors:Labcorp Drug Development, ICON plc, IQVIA, PPD (Thermo Fisher Scientific)
LEADERSHIP
Key Executives:
Gilles Martin - CEO (Eurofins Group)
LINKS
Website:bcl.eurofins.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Eurofins Central Laboratory. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.